








































































































































without bile duct resecion5Extended lt.hepatectomy















*S1; combined resection of the caudate lobe
**S1, S4, S5; according to the classification of Cuinoud
　表２．検索リンパ節個数












































































































































































1. Each lymph node was serially sectioned at 40μm intervals for multiple steps. Two sections was 
made at one section, one was for immunohistochemical staining to detect micro-metastases, and the 
other was used for hematoxylin and esoin staining to oberve the morph of cyto keratin positive cells.
2. Sections were counted 17.1 pieces from each lymph node. 











































a,b：Immunohistochemical detection for micrometasis with monoclonal antibody cocktail CAM5.2 in 
case 1. hematoxylin and eosin staining reveals its morph was malignancy.
c,d  ：case 3.

















































































































  *According to JSBS (Japanese Society of Biliary Systems) Classifcation of Biliary Tract Carcinoma
　 (First English Edition)
 **pericholedocal lymph node
***post hepatic artery lymph node









































































































































  * mod; moderately differentiated type
 ** por; poorly differentiated type


































































































































































































Papillary or Well 
　　　Differentiated
　　　Others




























































































































































































of the Venous System
　　　Present
　　　Absent

























































































































に ２mm未 満 の 転 移 巣 が 認 め た 場 合 を
micrometastases と 定 義 し て い る。 A J C C 


























































































































































































IHC ; immunohistochemistry,　　n/a ; not assessed　　ND ; no defference
"Adverse" ; adverse prognosis　　 n/a ; not assessed　　CEA ; carcinoembryonic antigen,
CAM5.2 ; anticytokeratin antibody(Becton Dikinson,CA)
BerEP4 ; epithelial membrane antigen
AE1/AE3 ; anticytokeratin antibody(Boehringer-Mannheim,IN)
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"Adverse" ; adverse prognosis　
櫻井，木村
－107－
cancer. Clin Exp Metastasis 1999;17: 593-599
5．Sloane JP, :Molecules and micrometastases. 
Lancet 1995; 345: 1255-1256
6．Hermanek P : Classification of isolated tumor 
cell and micrometastasis. Cancer1999; 86: 2668-
2673
7．Ghossein R A,Bhattacharya S,Rosai J: Molecu-
lar detection of micrometastases and circulat-
ing tumor cells in solid tumors.Clin Cancer 
Res1999; 5:1950-1960 
8．Nakamura T, et al.: Clinical implications of 
lymph node micrometastasis in patients with 
histologically node negative (pN0) esophageal 
carcinoma. J Surg Oncol 2002; 79: 224-229
9．Nimura Y, et al.: Aggressive preoperative 
management and extended surgery for hilar 
cholangiocarcinoma: Nagoya experience. J 
Hepatobiliary Pancreat Surg 2000; 7: 155-162
10．Tsukada K, et al.: Lymph node spread from 
carcinoma of the gallbladder. Cancer 1997; 80: 
661-667
11．Kurosaki I, Hatakeyama K, Tsukada K: 
Long-term survival of patients with biliary 
tract cancers with lymph node involvement. J 
Hepatobiliary Pancreat Surg 1999; 6: 399-400
12．Ogura Y, et al.: Radical operations for 
carcinoma of the gallbladder: present status in 
Japan. World J Surg1991; 15: 337-343
13．永川宅和，萱原正都 : 胆道癌治療成績からみた
胆道癌治療の実態．胆道　2000；14：23-28 ．
14．Tsukada K, et al.: Outcome of radical 
surgery for carcinoma of the gallbladder 
according to the TNM stage. Surgery 1996; 
120: 816-821
15．Muratore A, Polastri R, Capussotti L, 
Radical surgery for gallbladder cancer: current 
options. Eur J Surg Oncol 2000; 26: 438-443
16．Wakai T, et al.: Early gallbladder carcinoma 
does not warrant radical  resection. Br J Surg 
2001; 88: 675-678
17．Orth K, Beger HG: Gallbladder carcinoma 
and surgical treatment. Langenbecks Arch 
Surg 2000; 385: 501-508
18．Yamamoto  M, et al.: Surgical results of 
operations for carcinoma of the gallbladder. 
Hepatogastroenterology 1999; 46: 1552-1556
19．Yamaguchi  K, et al.: Retrospective analysis 
of 70 operations for gallbladder carcinoma. Br J 
Surg 1997; 84: 200-204
20．Yokoyama  N, Shirai Y, Hatakeyama K: 
Immunohistochemical detection of lymph node 
micrometastases from gallbladder carcinoma 
using monoclonal anti-cytokeratin antibody. 
Cancer 1999; 85: 1465-1469
21．Nagakura  S, et al.:Clinical significance of 
lymph node micrometastasis in gallbladder 
carcinoma. Surgery 2001; 129: 704-713
22．Okami J, et al.: Genetic detection for 
micrometastasis in lymph node of biliary tract 
carcinoma. Clin Cancer Res 2000; 6: 2326-2332
23． Sobin LH, Wittekind Ch, eds.: TNM 
classification of Malignant Tumors. 6th ed. In: 
International Union Against Cancer.New York; 
Wiley-Liss, 2002: 81-83
24．Sloane JP, Ormerod MG, Neville AM: 
Potential pathological  application of immuno-
cytochemical methods to the detection of 
micrometastases. Cancer Res 1980; 40: 3079-
3082
25．Galea MH, et al.: Occult regional lymph node 
metastases from breast carcinoma: immunohis-
tological detection with antibodies CAM 5.2 
and NCRC-11. J Pathol 1991; 165: 221-227
26．Mori M, et al.: Detection of cancer micro-
metastases in lymph nodes by reverse 
transcriptase-polymerase chain reaction. Can-
cer Res 1995; 55: 3417-3420
27．Nagakawa T, ed.: Classification of Biliary 
Tract Carcinoma. 1st ed. In: Japanese Society 
of Biliary Surgery(JSBS). Totyo; Kanehara & 
Co., Ltd., 2001: 7-10
28．Natsugoe S, et al.: Occult lymph node 
metastasis in gastric cancer with submucosal 
invasion. Surg Today 1994; 24:  870-875.
29．Saphir O, Amromin G: Obscure axillary 
lymph metastasis in carcinoma  of the breast. 
微小転移の検出方法の確立と予後との関連について
－108－
Cancer 1948; 14: 1266-1271
30．O'Brien MJ, Zamcheck N, Burke B, Kirkham 
SE, Saravis CA, Gottlieb LS: Immunocyto-
chemical localization of carcinoembryonic 
antigen in benign and malignant colorectal 
tissues. Assessment of diagnostic value: Am J 
Clin Pathol 1981; 75: 283-290
31．Makin CA, Bobrow LG, Nicholls RJ: Can 
immunohistology  improve detection of lymph 
node metastases in large bowel cancer ? Dis 
ColonRectum1989; 32: 99-102
32．Davidson BR, Sams VR, Styles J, Deane C, 
Boulos PB: Detection of occult nodal metasta-
ses in patients with colorectal carcinoma. 
Cancer1990; 65: 967-970
33．Liefers GJ, Cleton-Jansen AM, van de Velde 
CJ, Hermans J,van Krieken JH, Cornelisse C 
J,Tollenaar RA: Micrometastases and survival 
in stage II colorectal cancer. N Engl J Med 
1998; 339: 223-228
34．Cutait R, Alves VA, Lopes LC, Cutait DE, 
Borges JL, Singer J, da Silva H, Goffi FS: 
Restaging of colorectal cancer based on the 
identification of lymph node micrometastases 
through immunoperoxidase staining of CEA 
and cytokeratins. Dis Colon Rectum 1991; 34: 
917-920
35．Nicholson AG, Marks CG, Cook MG: Effect 
on lymph node status of triple levelling and 
immunohistochemistry with CAM 5.2 on node 
negative colorectal carcinomas. Gut 1994; 35: 
1447-1448
36．Greenson JK, Isenhart CE, Rice R, Mojzisik 
C, Houchens D, Martin Jr EW: Identification of 
occult micrometastases in pericolic lymph 
nodes of Dukes' B colorectal cancer patients 
using monoclonal antibodies against cytokera-
tin and CC49. Correlation with long-term 
survival. Cancer1994; 73: 563-569
37．Oberg A, Stenling R, Tavelin B, Lindmark G: 
Are lymph node micrometastases of any clinical 
significance in Dukes Stages A and B colorectal 
cancer ?. Dis Colon Rectum1998; 41: 1244-1249
38．Isaka N, Nozue M, Doy M, Fukao K: 
Prognostic significance of perirectal lymph 
node micrometastases in Dukes' B rectal 
carcinoma: an immunohistochemical study by 
CAM5.2 . Clin Cancer Res1999; 5: 2065-2068
39．Haboubi NY, Clark P, Kaftan SM, Schofield 
PF: The importance of combining xylene 
clearance and immunohistochemistry in the 
accurate staging of colorectal carcinoma. JR 
Soc Med1992; 85: 386-388
40．Jeffers MD, O'Dowd GM, Mulcahy H, Stagg 
M, O'Donoghue DP, Toner M: The prognostic 
significance of immunohistochemically de-
tected lymph node micrometastases in colorec-
tal carcinoma. J Pathol 1994; 172: 183-187
41．Cote RJ, Houchens DP, Hitchcock CL, Saad 
AD, Nines R , Greenson JK, Schneebaum S, 
Arnold MW, Martin Jr. EW: Intraoperative 
detection of occult colon ancermicrometastases 
using 125 I-radiolabled monoclonal antibody 
CC49. Cancer 1996; 7: 613-620
42．Adell G, Boeryd B, Franlund B, Sjodahl R, 
Hakansson L: Occurrence and prognostic 
importance of micrometastases in regional 
lymph nodes in Dukes' B colorectal carcinoma: 
an immunohistochemical study. Eur J Surg 
1996; 162: 637-642
43．Broll  R, Schauer V, Schimmelpenning H, 
Strik M, Woltmann A, Best R, Bruch HP, 
Duchrow M: Prognostic relevance of occult 
tumor cells in lymph nodes of colorectal 
carcinomas: an immunohistochemical study. 
Dis Colon Rectum 1997; 40: 1465-1471
44．Hitchcock  CL, Sampsel J, Young  DC, 
Martin, Jr EW, Arnold MW: Limitations with 
light microscopy in the detection of colorectal  
cancer cells. Dis Colon Rectum 1999; 42: 1046-
1052
45．Deguchi T, Doi T, Ehara H, Ito S, Takahashi 
Y, Nishino Y, Fujihiro S, et al.: Detection of 
micrometastatic prostate cancer cells in lymph 
nodes by reverse transcriptase-polymerase 
chain reaction. Cancer Res 1993; 53: 5350-5354
櫻井，木村
－109－
46．Neville AM, Price KN, Gelber RD, Gold-
hirsch A: Axillary node micro-metastases and 
breast cancer. Lancet 1991; 337: 1110
47．Huvos AG, Hutter R V, Berg J W : Signifi-
cance of axillary macrometastases and micro-
metastases in mammary cancer. Ann Surg 
1971; 173: 44-46
48．Frederick LG, David LP, Irvin DF, April GF, 
Charles MB, Daniel GH, Monica M, eds.: AJCC 
Cancer staging handbook 6th ed. In: American 
Joint Committee on Cancer. New York Berlin 
Heidelberg; Springer-Verlag, 2002: 260-263
49．Pelkey TJ, Frierson HF, Jr., Bruns DE: 
Molecular and immunological detection of 
circulating tumor cells and micrometastases 
from solid tumors. Clin Chem 1996; 42: 1369-
1381
50．Nakajo A, Natsugoe S, Ishigami S, Matsu-
moto M, Nakashima S, Hokita  S, Baba M, 
Takao S, Aikou T: Detection and prediction of 
micrometastasis in the lymph nodes of patients 
with pN0 gastric cancer. Ann Surg Oncol 2001; 
8: 158-162
51． Sasaki M, Watanabe H, Jass JR, Ajioka Y, 
Kobayashi M, Hatakeyama K: Immunoperoxidase 
staining for cytokerdtins 8 and 18 is very 
sensitive for detection of occult node me-
tastdsis of colorectal cancer: a compovison with 




Yamagata Med J 2003；21（2)：89-110
Background : Most commonly, the status of regional lymph node was examined by 
only one section in maximum diameter patho-logically. Therefore, the minute 
metastatic lesion was result in node negative. The most important disease-related 
prognostic factor in primary cancer of the digestive system is the status of regional 
lymph nodes. Recently, there are many reports about micro-metastases in various 
malignant tumors of the digestive systems. But it's prognostic significance remains to 
be clarified. 
Methods : The lymph nodes obtained from 19 node-negative patients in hilar bile 
duct cancer, 15 node-negative patients in pT2 gallbladder cancer, and 10 node-
negative patients in mid-and-lower bile duct cancer were sectioned at multi-level, and 
stained immuno-hisochemically for detecting micrometastases. And then the 
associations between micrometastases and other clinico-pathological variables and 
prognosis were assessed.
Results : Micrometastases were present in 6 cases (31.5%) in hilar bile duct cancer, 3 
cases (20.0%) in pT2 gallbladder cancer, and no case in mid-and-lower bile duct 
cancer. The presence of micro-metastases was unrelated to any clinicopathological 
factors, and they were not independent factors stastically. 
Conclusions： The presence of the micrometastases　detected by serial sectioning 
and immunohistochemistry did not have significant prognostic value  in primary 
cancer of the hepatobilialy system, a larger series would be found to dissolve this 
problem certainly.
Key words：micrometastases, serial section, immunohistchemistry, hilar bile duct 
carcinoma,  gallbladder carcinoma
Detection of the M icrometastasis and Its
 Prognostic Significance in M alignant Tumors 
of the Hepatobilialy Systems
Fumiaki Sakurai, Wataru Kimura
ABSTRACT
The First Department of Surgery, Yamagata University School of 
Medicine, Yamagata,  Japan
